I-O Optimise: a novel multinational real-world research platform in thoracic malignancies - Université Paris-Est-Créteil-Val-de-Marne Access content directly
Journal Articles Future Oncology Year : 2019

I-O Optimise: a novel multinational real-world research platform in thoracic malignancies

Abstract

Aim: To describe I-O Optimise, a multinational program providing real-world insights into lung cancer management. Materials & methods: Real-world data source selection for I-O Optimise followed a structured approach focused on population coverage, key variable capture, continuous/consistent data availability, record duration and data latency, and database expertise. Results: As of 31 October 2018, seven real-world data sources were included in I-O Optimise, providing data on characteristics, treatment patterns and clinical outcomes from more than 45,000 patients/year with non-small-cell lung cancer, small-cell lung cancer and mesothelioma across Denmark, Norway, Portugal, Spain, Sweden and the UK. Conclusion: The ongoing I-O Optimise initiative has the potential to provide a broad, robust and dynamic research platform to continually address numerous research objectives in the lung cancer arena.
Fichier principal
Vignette du fichier
fon-2019-0025.pdf (2.62 Mo) Télécharger le fichier
Origin : Publication funded by an institution

Dates and versions

hal-04145772 , version 1 (29-06-2023)

Identifiers

Cite

Simon Ekman, Frank Griesinger, Paul Baas, David Chao, Christos Chouaid, et al.. I-O Optimise: a novel multinational real-world research platform in thoracic malignancies. Future Oncology, 2019, 15 (14), pp.1551-1563. ⟨10.2217/fon-2019-0025⟩. ⟨hal-04145772⟩

Collections

IMRB UPEC
1 View
4 Download

Altmetric

Share

Gmail Facebook X LinkedIn More